A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multicenter, Multi-National Study For Evaluation Of Efficacy And Safety Of Du-176b Versus Warfarin In Subjects With Atrial Fibrillation – Effective Anticoagulation With Factor Xa Next Generation In Atrial Fibrillation.